Baldrian, Hopfen, Baldrian und Hopfen – pflanzliche Beruhigungsmittel

Zusammenfassung

Baldrian und Baldrian-Hopfen-Kombinationen werden häufig bei Schlafstörungen angewandt. Baldrianextrakte und einzelne Inhaltsstoffe zeigen in Tierversuchen anxiolytische und leicht sedierende Wirkungen. Einzelne wirksamkeitsbestimmende Inhaltsstoffe sind für Baldrian noch nicht bekannt. Hopfenzapfen wirken im Tierversuch sedierend, was auf die Kombination von Bittersäuren und ätherischem Öl zurückzuführen sein könnte. In klinischen Studien scheinen Baldrianpräparate die Schlaflatenz und kreisende Gedanken zu vermindern. In Kombinationspräparaten mit Hopfen kann eine leichte sedierende Wirkung festgestellt werden. Bis auf gastrointestinale Beschwerden sind Zubereitungen aus beiden Arzneipflanzen gut verträglich.

Summary

Valerian, hops, and valerian hops combinations

Valerian and valerian hops combinations are often applied against insomnia. Valerian extracts and single constituents show anxiolytic and slightly sedative effects in animal studies. The main active constituents have not been identified for valerian. Hop strobiles have a sedative effect in animal studies that might be due to the combination of bitter acids and the essential oil. In clinical studies, valerian root preparations seem to reduce both sleep latency and anxious thoughts. In combination with hops, a mildly sedative effect has been established. Except for gastrointestinal discomforts, preparations from both herbal drugs are generally well tolerated.

Schlüsselwörter

Valeriana officinalis L. s.l. - Humulus lupulus L. - Übersicht

Key words

Valeriana officinalis L. s.l. - Humulus lupulus L. - review

Literatur

• 1 Abourashed EA. Koetter U. Brattström A. In vitro bindung experiments with a valerian, hops and their fixed combination extract (ZE91019) to selected central nervous system receptors.  Phytomedicine. 2004;  11 633-638
• 2 Anderson GD. Elmer GW. Taibi DM. et al.. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.  Phytother Res. 2010;  24 1442-1446
• 3 Benke D. Barberis A. Kopp S. et al.. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts.  Neuropharmacology. 2009;  56 174-181
• 4 Cattoor K. Bracke M. Deforce D. et al.. Transport of hop bitter acids across intestinal Caco-2 cell monolayers.  J Agric Food Chem. 2010;  58 4132-4140
• 5 Chow NK. Fretz M. Hamburger M. Butterweck V. Telemetry as a tool to measure sedative effects of a valerian root extract and its single constituents in mice.  Planta Med. [in press] DOI: 10.1055/s-0030-1250589
• 6 Committee on Herbal Medicinal Products (HMPC) .Assessment report on Valeriana officinalis L., radix and Humulus lupulus L., flos. 2010 EMA/HMPC/215214/2008
• 7 Committee on Herbal Medicinal Products (HMPC) .Assessment report on Valeriana officinalis L.,radix. 2007 EMEA/HMPC/167391/2006
• 8 Committee on Herbal Medicinal Products (HMPC) .Community herbal monograph on Humulus lupulus L., Flos. 2008 EMEA/HMPC/513617/2006
• 9 Committee on Herbal Medicinal Products (HMPC) .Community herbal monograph on Valeriana officinalis L., Radix. 2006 EMEA/HMPC/3430719/2005
• 10 Committee on Herbal Medicinal Products (HMPC) .Community herbal monograph on Valerinan officinalis L., radix and Humulus lupulus L., flos. 2010 EMA/HMPC/585558/2007
• 11 Committee on Herbal Medicinal Products (HMPC) . Humulus lupulus L.,flos Assessment report for the development of community monographs and for inclusion fo herbal substances. 2008 EMEA/HMPC/513618/2006
• 12 Cornu C. Remontet L. Noel-Baron F. et al.. A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.  BMC Complement Altern Med. 2010;  10 29
• 13 Cuellar NG. Ratcliffe SJ. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?.  Altern Ther Health Med. 2009;  15 22-28
• 14 Del Valle-Mojica LM. Cordero-Hernandez JM. Gonzalez-Medina G. et al.. Aqueous and ethanolic Valeriana officinalis extracts change the binding of ligands to glutamate receptors.  Evid Based Complement Alternat Med. 2011;  2011 891819
• 15 Diaper A. Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults.  Phytother Res. 2004;  18 831-836
• 16 Dimpfel W. Akute Wirksamkeit eines Baldrianwurzel-Tockenextraktes auf die Schlaftiefe beim Menschen.  Z Phytother. 2007;  28 7-15
• 17 Dorn M. Wirksamkeit und Verträglichkeit von Baldrian versus Oxazepam bei nichtorganischen und nichtpsychiatrischen Insomnien: Eine randomisierte, doppelblinde, klinische Vergleichsstudie.  Forsch Komplementarmed Klass Naturheilkd. 2000;  7 79-84
• 18 Fernandez-San-Martin MI. Masa-Font R. Palacios-Soler L. et al.. Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials.  Sleep Med. 2010;  11 505-511
• 19 Hänsel R. Sticher O. Hrsg. Pharmakognosie Phytopharmazie. 9 Aufl. Heidelberg: Springer; 2010: 1451-0
• 20 Hattesohl M. Feistel B. Sievers H. et al.. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.  Phytomedicine. 2008;  15 2-15
• 21 Hellum BH. Hu Z. Nilsen OG. Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes.  Basic Clin Pharmacol Toxicol. 2009;  105 58-63
• 22 Jakovljevic V. Popovic M. Raskovic A. et al.. Effect of aroma and magnum hops extracts and paracetamol on antioxidant liver parameters in mice.  Eur J Drug Metab Pharmacokinet. 2009;  34 37-41
• 23 Koetter U. Schrader E. Kaufeler R. et al.. A randomized, double blind, placebocontrolled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.  Phytother Res. 2007;  21 847-851
• 24 Mohamed MF. Tseng T. Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity.  Xenobiotica. 2010;  40 663-669
• 25 Morin CM. Koetter U. Bastien C. et al.. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebocontrolled clinical trial.  Sleep. 2005;  28 1465-1471
• 26 Müller CE. Schumacher B. Brattstrom A. et al.. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors.  Life Sci. 2002;  71 1939-1949
• 27 Murphy K. Kubin ZJ. Shepherd JN. et al.. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.  Phytomedicine. 2010;  17 674-678
• 28 Preußler O. Hotzenplotz 3. Stuttgart: Thienemann; 1973
• 29 Rezvani ME. Roohbakhsh A. Allahtavakoli M. et al.. Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdalakindled rats: possible involvement of adenosine.  J Ethnopharmacol. 2010;  127 313-318
• 30 Schellenberg R. Sauer S. Abourashed EA. et al.. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism.  Planta Med. 2004;  70 1-5
• 31 Schiller H. Forster A. Vonhoff C. et al.. Sedierende Effekte von Extrakten aus Humulus lupulus L.  Z Phytother. 2009;  30 58-64
• 32 Schulz V. Hänsel R. Rationale Phytotherapie. 5. Aufl. Heidelberg: Springer; 2004: 125-126
• 33 Schumacher B. Scholle S. Holzl J. et al.. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.  J Nat Prod. 2002;  65 1479-1485
• 34 Stevinson C. Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials.  Sleep Med. 2000;  1 91-99
• 35 Taibi DM. Bourguignon C. Gill Taylor A. A feasibility study of valerian extract for sleep disturbance in person with arthritis.  Biol Res Nurs. 2009;  10 409-417
• 36 Taibi DM. Vitiello MV. Barsness S. et al.. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.  Sleep Med. 2009;  10 319-328
• 37 Vassiliadis T. Anagnostis P. Patsiaoura K. et al.. Valeriana hepatotoxicity.  Sleep Med. 2009;  10 935
• 38 Vonderheid-Guth B. Todorova A. Brattström A. et al.. Pharmacodynamic effects of valerian and hops extract combination (ZE 91019) on the quantitative-topographical EEG in healthy volunteers.  Eur J Med Res. 2000;  5 139-144
• 39 Ziegler G. Ploch, Miettinen-Baumann A, Collet W: Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia - a randomized, double-blind, comparative clinical study.  Eur J Med Res. 2002;  7 480-486